title: Health Canada releases guidance documents for subsequent entry biologics.
authors.affiliation: Gowling Lafleur Henderson LLP, Ottawa.
authors.forename: Scott
authors.initials: S
authors.lastname: Robertson
mesh_terms: D001688:Biological Products / Q000592:standards*; D002170:Canada; D033161:Government Regulation; D007880:Legislation, Drug; D009313:National Health Programs
chemical_list: D001688:Biological Products